ACC, AHA, HRS, HFSO, and SCAI leaders make the case for a new Board of Cardiovascular Medicine and share their insights and perspectives on the value of the new Board to cardiologists and patients. They also answer questions on all aspects of the Board, ranging from costs, to continuous competency, to what clinicians should do now to ensure a smooth transition if a new Board is approved.
Released: Nov. 15, 2023
Last Updated: September 2024